An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 11, Issue 9, Pages 2302
Publisher
MDPI AG
Online
2022-04-21
DOI
10.3390/jcm11092302
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology
- (2022) Fabio Salvatore Macaluso et al. DIGESTIVE AND LIVER DISEASE
- Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
- (2021) Séverine Vermeire et al. Journal of Crohns & Colitis
- ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
- (2021) T Kucharzik et al. Journal of Crohns & Colitis
- Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry
- (2021) María Chaparro et al. Journal of Crohns & Colitis
- Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
- (2021) Mathurin Fumery et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
- (2021) Brian G Feagan et al. LANCET
- 5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules?
- (2021) Hans Herfarth et al. Inflammatory Intestinal Diseases
- ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
- (2021) Tim Raine et al. Journal of Crohns & Colitis
- Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
- (2021) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
- (2021) Silvio Danese et al. Lancet Gastroenterology & Hepatology
- Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis
- (2020) Pablo Olivera et al. GASTROENTEROLOGY
- Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
- (2020) William J. Sandborn et al. GASTROENTEROLOGY
- Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis
- (2020) Hao-Yue Zhou et al. IMMUNOLOGICAL INVESTIGATIONS
- Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical Centre
- (2020) Martin Lukas et al. Journal of Crohns & Colitis
- REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY.
- (2020) Brigida Barberio et al. DIGESTIVE DISEASES
- TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update
- (2020) Marianne Vulliemoz et al. DIGESTION
- Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis
- (2020) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
- (2019) Gionata Fiorino et al. DIGESTIVE AND LIVER DISEASE
- Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis
- (2019) Carlos Taxonera et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Role of Early Biologic Therapy in Inflammatory Bowel Disease
- (2019) Dana Rachel Berg et al. INFLAMMATORY BOWEL DISEASES
- Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study
- (2019) Aurelien Amiot et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis
- (2019) Gerd R. Burmester et al. ADVANCES IN THERAPY
- Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients
- (2019) Christian P. Selinger et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
- (2019) Bruce E. Sands et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data
- (2019) Timothy Card et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis
- (2019) Edward L Barnes et al. INFLAMMATORY BOWEL DISEASES
- Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis
- (2019) Thomas Ochsenkühn et al. United European Gastroenterology Journal
- Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience
- (2018) P. Wils et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
- (2018) Caitriona Ryan et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease
- (2018) James D Lewis et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses
- (2018) Stefanos Bonovas et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn’s Disease or Ulcerative Colitis: a Systematic Review and Meta-analysis
- (2018) Laurent Peyrin-Biroulet et al. Clinical Gastroenterology and Hepatology
- Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
- (2018) Amy Hemperly et al. CLINICAL PHARMACOKINETICS
- Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study
- (2018) Carl Eriksson et al. GUT
- Neoplasia and Precursor Lesions of the Female Genital Tract in IBD: Epidemiology, Role of Immunosuppressants, and Clinical Implications
- (2018) Hanna M J L Hazenberg et al. INFLAMMATORY BOWEL DISEASES
- Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
- (2018) Joseph Meserve et al. Clinical Gastroenterology and Hepatology
- Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis
- (2018) Antonio Tursi et al. MEDICINE
- Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
- (2018) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- American Gastroenterological Association Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis
- (2018) Siddharth Singh et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on the Management of Mild-to-Moderate Ulcerative Colitis
- (2018) Cynthia W. Ko et al. GASTROENTEROLOGY
- Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies
- (2018) Julian Panés et al. Journal of Crohns & Colitis
- Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study
- (2017) Chang-Ho Ryan Choi et al. GUT
- Systematic Review and Meta-analysis
- (2017) Jean M. Chalhoub et al. INFLAMMATORY BOWEL DISEASES
- A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease
- (2017) Ditte V Mogensen et al. Journal of Crohns & Colitis
- Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
- (2017) David T. Rubin et al. Journal of Crohns & Colitis
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
- (2017) Marcus Harbord et al. Journal of Crohns & Colitis
- European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
- (2017) Glen Doherty et al. Journal of Crohns & Colitis
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
- (2017) Fernando Magro et al. Journal of Crohns & Colitis
- Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- (2017) Sudarshan Paramsothy et al. Journal of Crohns & Colitis
- A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis
- (2017) Taku Kobayashi et al. JOURNAL OF GASTROENTEROLOGY
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD
- (2017) Brigitte Moreau et al. Therapeutic Advances in Gastroenterology
- Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study
- (2016) V. Chhaya et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
- (2016) Paweł Kawalec et al. Archives of Medical Science
- Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
- (2016) Shailja C. Shah et al. Clinical Gastroenterology and Hepatology
- Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States
- (2016) William J. Sandborn et al. CURRENT MEDICAL RESEARCH AND OPINION
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel Disease
- (2016) M. Severs et al. Journal of Crohns & Colitis
- An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
- (2016) Tim Wyant et al. Journal of Crohns & Colitis
- Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review
- (2016) Zi Jian Luan et al. Journal of Digestive Diseases
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis
- (2016) Xinyun Qiu et al. Oncotarget
- Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study
- (2016) Christopher Ma et al. Canadian Journal of Gastroenterology and Hepatology
- Mesalazine in Inflammatory Bowel Disease: A Trendy Topic Once Again?
- (2016) Marietta Iacucci et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Inflammatory Bowel Disease: A Canadian Burden of Illness Review
- (2016) Angela Rocchi et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
- (2015) Gert Van Assche et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
- (2015) Andres J. Yarur et al. Clinical Gastroenterology and Hepatology
- Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
- (2015) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Granulocyte/Monocyte Adsorptive Apheresis in Moderate to Severe Ulcerative Colitis - Effective or Not?
- (2015) Wolfgang Kruis et al. DIGESTION
- A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease
- (2015) Andrea Michielan et al. DIGESTIVE AND LIVER DISEASE
- Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials
- (2015) Anthony Lopez et al. DIGESTIVE AND LIVER DISEASE
- Ulcerative Colitis Care Pathway
- (2015) Themistocles Dassopoulos et al. GASTROENTEROLOGY
- Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis
- (2015) Sanjay K. Murthy et al. INFLAMMATORY BOWEL DISEASES
- Infliximab-Related Infusion Reactions: Systematic Review
- (2015) Lev Lichtenstein et al. Journal of Crohns & Colitis
- European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
- (2015) Vito Annese et al. Journal of Crohns & Colitis
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Biologics for Extraintestinal Manifestations of IBD
- (2014) Stephan Vavricka et al. CURRENT DRUG TARGETS
- Can We Predict the High-Risk Patient?
- (2014) Jose-Manuel Benitez et al. DIGESTIVE DISEASES
- European evidence based consensus on surgery for ulcerative colitis
- (2014) Tom Øresland et al. Journal of Crohns & Colitis
- A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: Treatment outcomes of 847 patients in clinical practice
- (2014) Yoko Yokoyama et al. Journal of Crohns & Colitis
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- Ulcerative Colitis
- (2014) Joseph D. Feuerstein et al. MAYO CLINIC PROCEEDINGS
- A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
- (2014) Suk-Kyun Yang et al. NATURE GENETICS
- Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)
- (2014) Anne C Seagrove et al. BMJ Open
- Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab
- (2013) A. Croft et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis
- (2013) B. Flourié et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical Risk Factors for Complicated Disease: How Reliable Are They?
- (2013) Camille Zallot et al. DIGESTIVE DISEASES
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
- (2013) Simon P L Travis et al. GUT
- Safety of Thiopurine Therapy in Inflammatory Bowel Disease
- (2013) María Chaparro et al. INFLAMMATORY BOWEL DISEASES
- Duration of Disease May Predict Response to Infliximab in Pediatric Ulcerative Colitis
- (2013) Sabina A.V. Mir et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Tolerability of one hour 10mg/kg infliximab infusions in inflammatory bowel diseases: A prospective multicenter cohort study
- (2013) Abdenour Babouri et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients
- (2013) William Zabala et al. PHARMACOGENOMICS
- Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease
- (2012) M. Chaparro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort
- (2012) Laura E Targownik et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
- (2012) Debanjali Mitra et al. BMC GASTROENTEROLOGY
- Second-Generation Corticosteroids for the Treatment of Crohns Disease and Ulcerative Colitis: More Effective and Less Side Effects?
- (2012) Chiara De Cassan et al. DIGESTIVE DISEASES
- Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
- (2012) William J. Sandborn et al. GASTROENTEROLOGY
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
- (2012) David Laharie et al. LANCET
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: loss of response to anti-TNF treatments in Crohn’s disease
- (2011) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study
- (2011) T. W. Lee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing - ASCEND I and II combined analysis
- (2011) G. R. Lichtenstein et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis
- (2011) Xavier Roblin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Severity of Inflammation as a Predictor of Colectomy in Patients With Chronic Ulcerative Colitis
- (2011) Marco M. Hefti et al. DISEASES OF THE COLON & RECTUM
- Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease
- (2011) Harminder Singh et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study
- (2011) Mats Sjöberg et al. INFLAMMATORY BOWEL DISEASES
- Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
- (2011) Joana Torres et al. INFLAMMATORY BOWEL DISEASES
- A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization
- (2010) Abderrahim Oussalah et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
- (2010) William J. Sandborn et al. GASTROENTEROLOGY
- Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
- (2009) J. P. GISBERT et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease
- (2009) M J L Romberg-Camps et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan
- (2009) T. Hibi et al. DIGESTIVE AND LIVER DISEASE
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial
- (2008) Robert D. Inman et al. ARTHRITIS AND RHEUMATISM
- Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker
- (2008) S. Danese DIGESTIVE AND LIVER DISEASE
- MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis
- (2008) Mary Y Hu et al. EXPERT OPINION ON PHARMACOTHERAPY
- European evidence-based Consensus on the management of ulcerative colitis: Special situations
- (2008) Livia Biancone et al. Journal of Crohns & Colitis
- Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
- (2008) Inger Camilla Solberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More